跳至主要内容
临床试验/IRCT201101095579N1
IRCT201101095579N1已完成未知

Atorvastatin effect on lung function and serum level of hs-CRP in chemical warfare patients with obstructive pulmonary disease.

Ardabil University Of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 85 years(—)
性别
Male

入选标准

  • Chemical warfare victims with obstructive pulmonary disease; age between 35-85; clinically stable disease in previous 8 weeks; acceptance of study design by patients.
  • Exclusion criteria: Active infectious disease; bronchiectasis; chronic inflammatory diseases; soft tissue diseases; active liver and kidney diseases; cancer; cardiac disease (myocardial infarction and unstable angina in previous 6 months); sensitivity to atorvastatin; myopathy; myositis; hypercholestrolemia history; history of atorvastatin consumption; history of smoking; asthma; elevated CPK and elevated liver function test more than twice.

排除标准

  • 未提供

研究者

相似试验

Aatorvastatin effect on lung function and serum... | 临床试验